Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Effectiveness of participatory video in lowering stigma against people with mental, neurological and substance use disorders in Kenya.

Bitta MA. et al, (2023), BJPsych Open, 9

Psycho-pharmacomicrobiomics: A Systematic Review and Meta-analysis.

Minichino A. et al, (2023), Biol Psychiatry

Predictors of positive patient-reported outcomes from 'Early Intervention in Psychosis': a national cross-sectional study.

Williams R. et al, (2023), BMJ Ment Health, 26

Improving our Understanding of Early Psychosis: Learning from the Optimise Trial.

Lennox B., (2023), Schizophr Bull, 49, 829 - 830

Assessing violence risk in first-episode psychosis: external validation, updating and net benefit of a prediction tool (OxMIV).

Whiting D. et al, (2023), BMJ Ment Health, 26

What happens after early intervention? Mapping early intervention in psychosis care pathways in the 12 months after discharge.

Puntis S. et al, (2023), Early Interv Psychiatry

Predictive tools in psychosis: what is ‘good enough’?

Seyedsalehi A. and Lennox B., (2023), Nature Reviews Neurology

The serum metabolomic profile of a distinct, inflammatory subtype of acute psychosis.

Lennox B. et al, (2022), Mol Psychiatry

Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.

Al-Diwani A. et al, (2022), Brain, 145, 2742 - 2754

Investigating the pro-cognitive and anti-depressant efficacy of metformin: A systematic review and meta-analysis of randomised controlled trials.

Nibber A. et al, (2022), J Affect Disord, 310, 52 - 59

Time to re-evaluate the risks and benefits of valproate and a call for action.

Howes OD. et al, (2022), Br J Psychiatry, 1 - 3

The early impact of the COVID-19 pandemic on patients with severe mental illness: An interrupted time-series study in South-East England.

Penington E. et al, (2022), Eur Psychiatry, 65

Challenging the psychiatry-neurology divide: the case of autoimmune encephalitis.

Lennox BR., (2022), Nat Rev Neurol

The psychological journey of weight gain in psychosis.

Waite F. et al, (2022), Psychol Psychother

Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis.

Safadi JM. et al, (2022), Mol Psychiatry, 27, 141 - 153

Immunopsychiatry in 2021: premise to promise, and back again.

Al-Diwani A. et al, (2022), Lancet Psychiatry, 9, 11 - 12

Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort.

Minichino A. et al, (2021), Mol Psychiatry, 26, 6269 - 6276

Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case-control study at 7 T.

Godlewska BR. et al, (2021), Transl Psychiatry, 11

Enhancing psychological safety in mental health services.

Hunt DF. et al, (2021), Int J Ment Health Syst, 15

The Early Youth Engagement in first episode psychosis (EYE-2) study: pragmatic cluster randomised controlled trial of implementation, effectiveness and cost-effectiveness of a team-based motivational engagement intervention to improve engagement.

Greenwood K. et al, (2021), Trials, 22

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?